Literature DB >> 30624085

Investigating the Hypothesis of Stress System Dysregulation as a Risk Factor for Central Serous Chorioretinopathy: A Literature Mini-Review.

Fabio Scarinci1, Cristina Mihaela Ghiciuc2, Francesca Romana Patacchioli3, Maura Palmery3, Mariacristina Parravano1.   

Abstract

Background: This mini-review addressed the question "what do we know about the association between the dysregulation of stress systems (HPA axis and SAM) and the onset and prognosis of CSC in adult populations?"
Methods: The literature mini-review was conducted through electronic searches using the PubMed, Web of Science, and Scopus databases. All published human and animal studies with both observational and experimental designs from 1966 to October 2018 were included.
Results: Our search identified 229 reports, of which 32 articles were ultimately identified to be reviewed in this paper. Among these key articles, twenty-three were related to exogenous and/or endogenous high glucocorticoids as risk factors for CSC, seven were related to Type-A behavior and chronic psychological distress as risk factors for idiopathic CSC, and two were related to stress-induced animal models of CSC. Nineteen out of twenty-three studies in the first group reported a consistent association between high circulating corticosteroids and the onset and prognosis of CSC. Six out of seven studies in the second group reported a consistent association between stress-induced allostatic (over)load and the appearance of more- or less-severe CSC disorders, assuming that elevated circulating steroids may constitute a kind of risk factor for the eye through dysregulation of the HPA axis. All the selected studies reported HPA axis dysregulation as a possible common factor to explain the association between high circulating corticosteroids and CSC. In contrast, the involvement of the SAM system is only indirectly taken into consideration through the PA and HR measures and/or plasma and 24-h urinary catecholamine levels. Therefore, information regarding the involvement of SAM system dysregulation in the onset and prognosis of CSC is lacking. This observation is particularly relevant in view of the fact that animal models of CSC in monkeys are primarily induced by adrenergic hypertonia and that the course of experimental CSC is not further exacerbated by the administration of corticosteroids.

Entities:  

Keywords:  CSC risk (factors); Cortisol; hypothalamic–pituitary–adrenal (HPA) axis; hypothalamic–pituitary–adrenal (HPA) axis dysregulation; stress; sympathetic adrenomedullary system (SAM); systemic corticosteroid therapy

Mesh:

Year:  2019        PMID: 30624085     DOI: 10.1080/02713683.2019.1565891

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  10 in total

Review 1.  Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Authors:  Pushpinder Kanda; Arnav Gupta; Chloe Gottlieb; Rustum Karanjia; Stuart G Coupland; Manpartap Singh Bal
Journal:  Eye (Lond)       Date:  2021-10-15       Impact factor: 4.456

2.  Author Response: Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy.

Authors:  Fabio Scarinci; Francesca Romana Patacchioli; Eliana Costanzo; Mariacristina Parravano
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

3.  Assessment of the safety of intravitreal injection of metoprolol tartrate in rabbits.

Authors:  Mayara Rodrigues Brandão de Paiva; Raquel Gregório Arribada; Carolina Nunes da Silva; Marcela Coelho Silva Ribeiro; Rodrigo Jorge; Silvia Ligório Fialho; Armando Silva-Cunha
Journal:  Doc Ophthalmol       Date:  2020-07-04       Impact factor: 2.379

4.  Central Serous Chorioretinopathy and Blood Serotonin Concentrations.

Authors:  Takeshi Kimura; Takashi Araki; Yuki Komuku; Hisashi Iwami; Fumi Gomi
Journal:  J Clin Med       Date:  2021-02-03       Impact factor: 4.241

5.  Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy.

Authors:  Fabio Scarinci; Francesca Romana Patacchioli; Eliana Costanzo; Mariacristina Parravano
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.925

6.  Intima-Media Thickness Measurements of the Common Carotid Artery in Patients with Central Serous Chorioretinopathy: A Case-Control Study.

Authors:  Kobra Nasrollahi; Amirhossein Farahi; Fatemeh Paknazar; Mohamadreza Akhlaghi; Farhad Fazel; Ehsan Zarepur; Mohsen Pourazizi
Journal:  J Ophthalmol       Date:  2021-09-04       Impact factor: 1.909

7.  Biopsychosocial Illness Model: From the Lung to the Eye.

Authors:  Fabio Scarinci; Mariacristina Parravano; Francesca Romana Patacchioli
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

Review 8.  Central Serous Chorioretinopathy and Personality Characteristics: A Systematic Review of Scientific Evidence over the Last 10 Years (2010 to 2020).

Authors:  Giovanni Genovese; Alessandro Meduri; Maria Rosaria Anna Muscatello; Sebastiano Gangemi; Clemente Cedro; Antonio Bruno; Pasquale Aragona; Gianluca Pandolfo
Journal:  Medicina (Kaunas)       Date:  2021-06-16       Impact factor: 2.430

9.  Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy.

Authors:  Meenakshi Kumar; Elon H C van Dijk; Rajiv Raman; Pooja Mehta; Camiel J F Boon; Abhilash Goud; Seelam Bharani; Jay Chhablani
Journal:  BMC Ophthalmol       Date:  2020-03-06       Impact factor: 2.209

10.  Central serous chorioretinopathy and heart rate variability analysis with a smartphone application.

Authors:  Keigo Takeshima; Koji Tanaka; Ryusaburo Mori; Yu Wakatsuki; Hajime Onoe; Takuya Sakakibara; Yorihisa Kitagawa; Hiroyuki Nakashizuka; Norihiro Tsuchiya
Journal:  Sci Rep       Date:  2020-09-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.